SNSS - Sunesis Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Sunesis Pharmaceuticals's activity chart (see below) currently has 2 price targets and 3 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 71.43% with an average time for these price targets to be met of 274.71 days.

Most recent stock forecast was given by from OPPENHEIMER on 23-Feb-2021. First documented stock forecast 11-Jun-2014.

Best performing analysts who are covering SNSS - Sunesis Pharmaceuticals:

Andrew Peters Mara Goldstein Jim Birchenough Hartaj Singh Joseph Pantginis Andrew Fein

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 08-Mar-2019

$12

$-1.28 (-9.64%)

5 years 8 months 2 days ago
(23-Feb-2021)

1/2 (50%)

$-2.98 (-19.89%)

544

Hold Since 11-Mar-2020

$10

6 years 5 months 17 days ago
(08-May-2020)

1/1 (100%)

$-12.05 (-54.65%)

107

Buy Since 11-Dec-2017

$10

$-3.28 (-24.70%)

$80

6 years 7 months 14 days ago
(11-Mar-2020)

3/3 (100%)

$-12.05 (-54.65%)

200

Hold Since 02-May-2017

$30

$16.72 (125.90%)

$50

8 years 10 months 20 days ago
(05-Dec-2017)

2/2 (100%)

$-53.65 (-64.14%)

449

Buy

$360

$346.72 (2610.84%)

11 years 3 months 1 days ago
(24-Jul-2015)

0/1 (0%)

$158.61 (78.76%)

Show more analysts

Please expand the browser size to see the chart

What is SNSS (Sunesis Pharmaceuticals) average time for price targets to be met?

On average it took 275 days for the stock forecasts to be reached, with an average price target met ratio of 71.43%.

Which analyst most recently updated their price target on SNSS (Sunesis Pharmaceuticals)?

Which analyst has the most public recommendations on SNSS (Sunesis Pharmaceuticals)?

has 0 price targets and 0 ratings on SNSS

Which analyst is the currently most bullish on SNSS (Sunesis Pharmaceuticals)?

Andrew Peters with the highest potential upside of $826.72

Which analyst is the currently most reserved on SNSS (Sunesis Pharmaceuticals)?

Jim Birchenough with the lowest potential downside of -$3.28
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?